Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3875-3893
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 100
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 35
New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 2
CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
Qi Lv, Yishu Zhang, Wenxue Gao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107126-107126
Open Access | Times Cited: 12
A new era in cancer treatment: harnessing ZIF-8 nanoparticles for PD-1 inhibitor delivery
Farangis Rastin, Mahsa Akbari Oryani, Sonia Iranpour, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 4, pp. 872-894
Closed Access | Times Cited: 18
Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts
Daisuke Shimizu, Ryo Yuge, Yuki Kitadai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7001-7001
Open Access | Times Cited: 7
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization
Lv Guangzhao, Xin Wang, Wu Miaoqing, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
Immunotherapy for colorectal cancer
Bing Yu, Jian Kang, Hong Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair–proficient colorectal cancer: preliminary results of a phase 2 study
Ying Liu, Jufeng Wang, Yong Fang, et al.
International Journal of Colorectal Disease (2025) Vol. 40, Iss. 1
Open Access
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 166-166
Open Access
Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy
Huan Gong, J. Daniel Griffin, Chad E. Groer, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer
Xiaofei Li, Yu-Wen Dong, Tingyu Wang, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114212-114212
Closed Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway
Longhai Li, Zhaoshuai Ji, Guangyun Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318776-e0318776
Open Access
Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis
Linfeng Liu, Dengzhuo Chen, Liang Wen, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
PD-1 inhibition disrupts collagen homeostasis and aggravates cardiac dysfunction through endothelial-fibroblast crosstalk and EndMT
Zejin Zhang, Zhenzhen Yan, Tao Yuan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
HIV-Helminth Co-Infections and Immune Checkpoints: Implications for Cancer Risk in South Africa
Botle Precious Damane, Thanyani Victor Mulaudzi, Shakeel Kader, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 451-451
Open Access
High-dose Vitamin C inhibits PD-L1 expression by activating AMPK in colorectal cancer
Jia Huang, Su Min, Ruiyang Hong, et al.
Immunobiology (2025), pp. 152893-152893
Open Access
Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors
Anna Arecco, Cristian Petolicchio, Alessandro Pastorino, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Prognostic Significance of B7H3 Expression in Solid Tumors: A Systematic Review and Meta-Analysis
Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3044-3044
Open Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Precision Medicine in Immunoradiotherapy
Jianfeng Feng, Jiakuan Peng, Hui Qiu, et al.
(2025), pp. 263-303
Closed Access
Page 1 - Next Page

Scroll to top